376. Long Term Outcomes of a Pilot Single-Blinded, Randomized Controlled Trial Comparing BNT162b2 vs JNJ-78436735 Vaccine as the Third Dose after Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients

BACKGROUND: Due to immunosuppressive medication, the immunogenicity after COVID-19 vaccination is suboptimal and durability in Solid Organ Transplant (SOT) recipients is still questionable. Thus, booster dose has been studied to improve not only the short but also long-term immunogenicity. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Natori, Yoichiro, Martin, Eric F, Mattiazzi, Adela, Sota, Katherine Alexandra, Viotti, Julia Bini, Anjan, Shweta, Guerra, Giselle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678189/
http://dx.doi.org/10.1093/ofid/ofad500.446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678189/
http://dx.doi.org/10.1093/ofid/ofad500.446

Ejemplares similares